DIGP Digipath Inc (PK)

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report:

(Date of earliest event reported)

July 30, 2014

 

 

DigiPath, Inc.

(Exact name of registrant as specified in charter)

 

Nevada

(State or other Jurisdiction of Incorporation or Organization)

 

000-54239		27-3601979
(Commission File Number)		(IRS Employer Identification No.)

 

6450 Cameron St Suite 113

Las Vegas, NV 89118

(Address of Principal Executive Offices and zip code)

 

(702) 527-2060

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:

 

[  ]     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

[  ]     Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))

 

[  ]     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

[  ]     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

  

 

 

Item 7.01   Regulation FD Disclosure.

 

Press Release

 

On July 30, 2014, DigiPath, Inc. (“DigiPath”), issued a press release announcing that it was unaware of any corporate developments to explain the recent market activity of its securities. A copy of this press release is attached hereto as Exhibit 99.1.

 

The information referenced under Item 7.01 (including Exhibit 99.1 referenced in Item 9.01 below) of this Current Report on Form 8-K is being “furnished” under “Item 7.01. Regulation FD Disclosure” and, as such, shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section. The information set forth in this Current Report on Form 8-K (including Exhibit 99.1 referenced in Item 9.01 below) shall not be incorporated by reference into any registration statement, report or other document filed by DigiPath pursuant to the Securities Act of 1933, as amended (the “Securities Act”) or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

 

The filing of this Item 7.01 of this Current Report on Form 8-K shall not be deemed an admission as to the materiality of any information herein that is required to be disclosed solely by reason of Regulation FD. The press release contains references to our websites. Information on our websites is not incorporated by reference into this Current Report on Form 8-K and does not constitute a part of this Form 8-K

 

Item 9.01   Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.		Document Description
99.1		Press release dated July 30, 2014, DigiPath announcing that it was unaware of any corporate developments to explain the recent market activity of its securities

 

  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

	DigiPath, Inc.
	Date: July 30, 2014
	By:	/s/ Steven Barbee
		Steven Barbee
		Chief Executive Officer

 

 

 

DigiPath No New Corporate Developments

 

Las Vegas, NV, July 30, 2014 -- DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology solution provider that is expanding into the cannabis testing and education markets, announced today that has been no material development in its business and affairs not previously disclosed or, to its knowledge, any other reason to account for the recent unusual market action.

 

According to Steve Barbee, CEO of DigiPath, “We have noticed unusual price and volume increases for our securities over the last three trading days. While we appreciate the increased attention DigiPath is receiving from the market, we are unaware of any corporate developments outside of those previously disclosed in our filings with the Securities and Exchange Commission that would explain these increases.”

 

About DigiPath, Inc.

 

DigiPath, Inc. develops and markets affordable and accurate human and animal digital pathology solutions. The Company is rapidly expanding its line of services to serve the botanical, nutraceutical, and cannabis industries with industry-leading testing and education and training services.

 

For more information, go to: www.digipath.com and www.digipath.biz.

 

Information about Forward-Looking Statements

 

This press release contains “forward-looking statements” that include information relating to future events and future financial and operating performance. The words “may,” “might,” “would,” “will,” “expect,” “estimate,” “can,” “believe,” “potential” and similar expressions and variations thereof are intended to identify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management’s good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause these differences include, but are not limited to: fluctuations in demand for the Company’s products, the introduction of new products, the Company’s ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company’s liquidity and financial strength to support its growth, and other information that may be detailed from time-to-time in the Company’s filings with the United States Securities and Exchange Commission. An example of such forward looking statements in this press release include statements regarding the Company developing and completing new products and revenue growth. For a more detailed description of the risk factors and uncertainties affecting DigiPath, please refer to the Company’s recent Securities and Exchange Commission filings, which are available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

 

Contact;

DigiPath, Inc.

Investor Relations

888-552-4440

IR@digipath.com